期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | HEART & LUNG LetPub Score 5.2 50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | HEART LUNG | ||||||||||||||||||||||||
ISSN | 0147-9563 | ||||||||||||||||||||||||
E-ISSN | 1527-3288 | ||||||||||||||||||||||||
h-index | 65 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 4.20%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/heart-and-lung-the-journal-of-acute-and-critical-care/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/HL | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Mosby Inc. | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 1972 | ||||||||||||||||||||||||
每年文章數 | 145每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 14.61% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0147-9563%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[HEART & LUNG] 的評論 | 撰寫評論 |
作者: miss33 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-29 12:23:29 評論於 It may take longer if we can't find a reviewer. ![]() ![]() |
作者: miss33 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-29 12:22:38 評論於 Did you mean that there is not a single reviewer for what you said? ![]() ![]() |
作者: 自由在风里000 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-27 10:35:43 評論於 For ten days, there has been no news, and he always says "with edier". ![]() ![]() |
作者: 自由在风里000 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-27 10:33:50 評論於 Now, this state of mine has lasted for ten days. ![]() ![]() |
作者: 王王海波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-26 17:45:24 評論於 I have been with Endier all along, how long will this state last? It has been a week already. ![]() ![]() |
作者: miss33 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2025-01-26 12:19:26 評論於 The review was completed in one month, and after minor revisions, it was accepted. It is a good journal. ![]() ![]() |
作者: sci有投必中 領域: 医学 審稿時間: 12.0 month(s) 結果: 拒稿 撰寫評論 |
2025-01-09 01:34:29 評論於 It took nearly half a year, with feedback from two reviewers, but in the end the editor rejected it. You should have mentioned earlier that you didn't want the initial review, it wasted time. ![]() ![]() |
作者: hasuhasu 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-12-16 20:09:18 評論於 After 4 days with the editor, it will go directly to DIP, with the outcome unknown. ![]() ![]() |
作者: Vincent 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-05-14 16:58:56 評論於 The submission threshold is low, and the efficiency of manuscript processing is high, but it may be returned if no reviewer accepts the invitation. Currently submitted four times, one accepted after 4 months, three returned after a month with no reviewers ![]() ![]() |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us